Your browser doesn't support javascript.
loading
Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study.
Reece, Donna E; Sanchorawala, Vaishali; Hegenbart, Ute; Merlini, Giampaolo; Palladini, Giovanni; Fermand, Jean-Paul; Vescio, Robert A; Liu, Xiangyang; Elsayed, Yusri A; Cakana, Andrew; Comenzo, Raymond L.
Affiliation
  • Reece DE; Princess Margaret Hospital, University Health Network, Toronto, ON, Canada. donna.reece@uhn.on.ca
Blood ; 114(8): 1489-97, 2009 Aug 20.
Article in En | MEDLINE | ID: mdl-19498019
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Amyloidosis Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2009 Type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Amyloidosis Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2009 Type: Article Affiliation country: Canada